Quarterly report · Q3
3154.TEDINET S100RJV8
Period2022-07-01 → 2023-03-31
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amends S100QPVK.
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥181.4bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥226.6bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥173.7bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.7bn | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.9bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.6bn | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥2.5bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥105.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥93.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥100.5bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥87.4bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥75.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥18.4bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.3bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥11.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥81.92 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥42.72 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.3 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥116.21 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.81 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥81.67 | 2022-07-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.15 | 2021-07-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥116.11 | 2021-07-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 17.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 18.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 24
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥176,000 |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥5.5bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥177.2bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥177.2bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥7.5bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥315m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥181.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥181.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥176,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥7.9bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥5.0bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥169.7bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥169.7bn |
| jpcrp040300-q3r_E22995-000Medical Equipment Salesreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥7.9bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥4.1bn |
| jpcrp040300-q3r_E22995-000Nursing Care And Welfarereportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥406m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-03-31 | ¥173.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-03-31 | ¥173.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-03-31 | ¥8.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 378
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任監査法人トーマツ | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)郷 右 近 隆 也 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)石 黒 宏 和 | |
| Number of submission | FilingDateInstant | 2 | |
| Net sales (5-year summary) | Prior1YTDDuration | 173723185000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 181388924000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 226606414000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 3675498000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 2777299000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2757877000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2543915000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1796097000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1867916000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 2237334000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1510461000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1803176000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 17741922000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 18401667000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 17307764000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 100545454000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 105835587000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 92953841000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 116.21 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 81.92 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 85.30 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 116.11 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 81.67 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 85.15 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.176 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.174 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.186 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 50.81 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 42.72 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21925104 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 21925104 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 21925104 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 21925104 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 900 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 21915900 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 219159 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 8304 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 21925104 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 219159 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 900 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |